Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
In this Perspective, we discuss various types of novel cisplatin-based Pt(iv) complexes including those targeting the tumor microenvironment.